新型コロナウイルスワクチン接種後心筋炎と心臓MRI所見-Reference-Cited by-同舟云学术

新型コロナウイルスワクチン接種後心筋炎と心臓MRI所見

Published:2023-08-01 Issue:2 Volume:39 Page:112-113
ISSN:0911-1794
Container-title:Pediatric Cardiology and Cardiac Surgery
language:en
Short-container-title:Ped Cardiol Card Surg

Author:

Seki Mitsuru¹

Affiliation:

1. Department of Pediatrics, Jichi Medical University

Publisher

The Japanese Society of Pediatric Cardiology and Cardiac Surgery

Subject

Polymers and Plastics,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/jspccs/39/2/39_EC2023-0004/_pdf

Reference14 articles.

1. 1) Tan SHX, Cook AR, Heng D, et al: Effectiveness of BNT162b2 vaccine against Omicron in children 5 to 11 years of age. N Engl J Med 2022; 387: 525–532

2. 2) Cohen-Stavi CJ, Magen O, Barda N, et al: BNT162b2 vaccine effectiveness against Omicron in children 5 to 11 years of age. N Engl J Med 2022; 387: 227–236

3. 3) Sacco C, Del Manso M, Mateo-Urdiales A, et al: Italian National COVID-19 Integrated Surveillance System and the Italian COVID-19 vaccines registry: Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: A retrospective analysis of January–April, 2022. Lancet 2022; 400: 97–103

4. 4) Zambrano LD, Newhams MM, Olson SM, et al: Overcoming COVID-19 Investigators: Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 years—United States, July–December 2021. MMWR Morb Mortal Wkly Rep 2022; 71: 52–58

5. 5) Shimabukuro T: Vaccines and related biological products advisory committee: Update on myocarditis following mRNA COVID-19 vaccination. June 7, 2022